Central Region, Central, Singapore Related Funds
Funds with similar focus
| Fund Name | Location |
| 3Rodeo | California, Los Angeles, United States |
| Ambit Pragma Ventures | India, Maharashtra, Mumbai |
| Bessemer Trust | New York, New York, United States |
| BioLife Solutions | Bothell, United States, Washington |
| Coghill Capital Management | Chicago, Illinois, United States |
| First Media | Indonesia, Jakarta, Jakarta Raya |
| Graphite Capital | England, London, United Kingdom |
| GreenSoil Investments | HaMerkaz, Israel, Ra'anana |
| Lacomp Plc | - |
| Massey Burch Capital Corporation | Nashville, Tennessee, United States |
| Niantic | California, San Francisco, United States |
| Omicron Media | Florida, United States, Winter Park |
| Protege VirtualManagement | - |
| Shenzhen Jinrong Dianzi Jiesuan Zhongxin | China, Guangdong, Shenzhen |
| SK Securities | Seoul-t'ukpyolsi, South Korea, Yongdungpo |
| W Investments | Canada, Montréal, Quebec |
| Zeal Capital Partners | District of Columbia, United States, Washington |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
OBVIOHEALTH | $19M | 08 Jun 2021 | Singapore, Central, Singapore | ||
Fibronostics | $8M | 24 Aug 2020 | Orlando, Florida, United States | ||
Lenddo | 14 Oct 2015 | Central |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
OBVIOHEALTH | $19M | 08 Jun 2021 | Singapore, Central, Singapore | ||
Fibronostics | $8M | 24 Aug 2020 | Orlando, Florida, United States | ||
Lenddo | 14 Oct 2015 | Central |
